NMDP to Present New Stem Cell Transplantation Data at the 2024 American Society of Clinical Oncology Annual Meeting NMDP to present new data on hematopoietic cell transplantation treatment effects in patients with hematological malignancies at ASCO.

National Marrow Donor Program® (NMDP)/Be The Match® Partners with New York Blood Center Enterprises Comprehensive Cell Solutions and Vitalant’s Cell Therapy Lab; Expands Access To Transplant The organization is increasing its cryopreservation service (formerly BioBank) to broaden support for transplant centers, patients, and their physicians.

Hematopoietic Stem Cells Transplantation Market revenue to cross USD 3.12 Billion by 2035, says Research Nester New York, July 10, 2023 (GLOBE NEWSWIRE) -- The global hematopoietic stem cells transplantation market is estimated to grow at a CAGR of ~10% from 2023 to 2035. The market is estimated to garner a...

Global Autologous Cell Therapy Market Is Expected to Reach USD 42.68 Billion by 2027 : Fior Markets Newark, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global autologous cell therapy market is expected to grow from USD 9.29 billion in 2019 and to reach...

Global Stem Cell Cartilage Regeneration Market to Surpass US$ 545 Million by 2026 - Coherent Market Insights Seattle, Jan. 25, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global stem cell cartilage regeneration market was valued at US$ 254.4 million in 2017, and is projected to...